PMID- 23315305
OWN - NLM
STAT- MEDLINE
DCOM- 20130627
LR  - 20210204
IS  - 1934-2403 (Electronic)
IS  - 1530-891X (Linking)
VI  - 18 Suppl 3
DP  - 2012 Nov-Dec
TI  - Current issues in GLP-1 receptor agonist therapy for type 2 diabetes.
PG  - 6-26; quiz 27-8
LID - 10.4158/EP12300.RA [doi]
AB  - The clinical management of hyperglycemia in patients with type 2 diabetes 
      mellitus (T2DM) is guided not only by published treatment algorithms, but also by 
      consideration of recent evidence and through consultation with colleagues and 
      experts. Recent studies have dramatically increased the amount of information 
      regarding the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). 
      Topics that may be of particular interest to clinicians who treat T2DM patients 
      include relative glycemic control efficacy of GLP-1 RAs, use of GLP-1 RAs across 
      T2DM progression and in combination with insulin, recent data regarding GLP-1 RA 
      safety, nonglycemic actions of GLP-1 RAs, including weight effects, and impact of 
      GLP-1 RAs on patient quality of life and treatment satisfaction. The following 
      review includes expert consideration of these topics with emphasis on recent, 
      relevant reports to illustrate current perspectives.
FAU - Bloomgarden, Zachary T
AU  - Bloomgarden ZT
AD  - Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, 
      Mount Sinai School of Medicine, New York, New York, USA. zbloom@gmail.com
FAU - Blonde, Lawrence
AU  - Blonde L
FAU - Garber, Alan J
AU  - Garber AJ
FAU - Wysham, Carol H
AU  - Wysham CH
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Endocr Pract
JT  - Endocrine practice : official journal of the American College of Endocrinology 
      and the American Association of Clinical Endocrinologists
JID - 9607439
RN  - 0 (Hypoglycemic Agents)
RN  - 89750-14-1 (Glucagon-Like Peptide 1)
SB  - IM
MH  - Diabetes Mellitus, Type 2/*drug therapy/*metabolism
MH  - Glucagon-Like Peptide 1/*agonists
MH  - Humans
MH  - Hypoglycemic Agents/therapeutic use
EDAT- 2013/01/15 06:00
MHDA- 2013/06/29 06:00
CRDT- 2013/01/15 06:00
PHST- 2013/01/15 06:00 [entrez]
PHST- 2013/01/15 06:00 [pubmed]
PHST- 2013/06/29 06:00 [medline]
AID - S1530-891X(20)43401-9 [pii]
AID - 10.4158/EP12300.RA [doi]
PST - ppublish
SO  - Endocr Pract. 2012 Nov-Dec;18 Suppl 3:6-26; quiz 27-8. doi: 10.4158/EP12300.RA.